[Microbiological monitoring in prophylaxis and treatment of pyoinflammatory complications during early postoperative period in patients with cicatricial tracheostenosis].
The species composition and antibiotic susceptibility of microflora isolated from patients with cicatricial tracheostenosis (CTS) and infectious processes were investigated. Schemes for the treatment of CTS with an account of the pathogen species and multidrug resistant staphylococcal infection are described. Comparative efficacy of the combined schemes (antibiotic + bacteriophage) for the therapy of pyoinflammatory processes in the patients with CTS and the efficacy of the treatment of the patients with CTS according to the traditional antibacterial schemes were studied.
Bondarenko
A V
AV
Larina
T A
TA
Bogomolova
N S
NS
Bol'shakov
L V
LV
D000293:Adolescent; D000328:Adult; D000368:Aged; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001424:Bacterial Infections / Q000150:complications / Q000517:prevention & control* / Q000628:therapy*; D001435:Bacteriophages; D001980:Bronchi / Q000382:microbiology; D002921:Cicatrix / Q000150:complications; D003131:Combined Modality Therapy; D003428:Cross Infection / Q000150:complications / Q000517:prevention & control* / Q000628:therapy*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D011184:Postoperative Period; D013492:Suppuration / Q000150:complications; D014132:Trachea / Q000382:microbiology; D014135:Tracheal Stenosis / Q000150:complications / Q000382:microbiology* / Q000601:surgery
D000900:Anti-Bacterial Agents